1 not yet recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Amit Mahipal: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maintenance Zanzalintinib and Durvalumab in Participants With Advanced Hepatocellular Cancer Durvalumab, Zanzalintinib - Hepatocellular Carcinoma, Liver Cancer | Phase 2 | Not yet recruiting | Amit Mahipal | 16 | 2026-05-01 | 2026-05-05 |
Carcinoma, Hepatocellular (1) · Liver Neoplasms (1)
durvalumab (1)
United States (1)